Skip to content
OpenCapital
AI Tools
Earnings
Screener
Charts
Watchlist
Pricing
Connect your AI
Get started
Toggle navigation menu
NTH
NTHI
NTHI
Return on equity
Return on equity at other companies
Bristol-Myers Squibb
BMY
38.8%
+7.3pp
Pfizer
PFE
10.6%
—
Merck & Co.
MRK
19%
-20.3pp
Nuvectis Pharma, Inc.
NVCT
-154.4%
+79.4pp
Oric Pharmaceuticals, Inc.
ORIC
-42.6%
-4.6pp
Nuvation Bio
NUVB
-39.5%
-15.8pp
Other financials
Income statement
See full
Revenue
$40.0K
-7.0%
Operating income
-$7.1M
+77.9%
Net income
-$8.8M
+72.7%
EPS (diluted)
-$0.38
+78.7%
Balance sheet
See full
Cash & equivalents
$138.6K
-97.5%
Total debt
$666.1K
—
Total equity
-$13.2M
-37.5%
Total assets
$3.3M
-60.6%
Cash flow
See full
Operating cash flow
-$7.0M
-23.7%
CapEx
$125.0K
—
Free cash flow
-$5.2M
—
Valuation
See full
Market cap
$114.62M
+51.0%
Enterprise value
$115.15M
+51.1%
P/S
1,432.9×
—
Profitability
See full
Operating margin
-46,870.7%
—
Net margin
-51,613.3%
—
FCF margin
-26,083.2%
—
Returns & leverage
See full
Debt / equity
-0.1×
—
Current ratio
0.1×
-0.3×